Skip to main content
Erschienen in: Intensive Care Medicine 6/2019

25.03.2019 | Seven-Day Profile Publication

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

verfasst von: Ignacio Martin-Loeches, Massimo Antonelli, Manuel Cuenca-Estrella, George Dimopoulos, Sharon Einav, Jan J. De Waele, Jose Garnacho-Montero, Souha S. Kanj, Flavia R. Machado, Philippe Montravers, Yasser Sakr, Maurizio Sanguinetti, Jean-Francois Timsit, Matteo Bassetti

Erschienen in: Intensive Care Medicine | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The term invasive candidiasis (IC) refers to both bloodstream and deep-seated invasive infections, such as peritonitis, caused by Candida species. Several guidelines on the management of candidemia and invasive infection due to Candida species have recently been published, but none of them focuses specifically on critically ill patients admitted to intensive care units (ICUs).

Material and Methods

In the absence of available scientific evidence, the resulting recommendations are based solely on epidemiological and clinical evidence in conjunction with expert opinion. The task force used the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach to evaluate the recommendations and assign levels of evidence. The recommendations and their strength were decided by consensus and, if necessary, by vote (modified Delphi process). Descriptive statistics were used to analyze the results of the Delphi process. Statements obtaining > 80% agreement were considered to have achieved consensus.

Conclusions

The heterogeneity of this patient population necessitated the creation of a mixed working group comprising experts in clinical microbiology, infectious diseases and intensive care medicine, all chosen on the basis of their expertise in the management of IC and/or research methodology. The working group’s main goal was to provide clinicians with clear and practical recommendations to optimize microbiological diagnosis and treatment of IC. The Systemic Inflammation and Sepsis and Infection sections of the European Society of Intensive Care Medicine (ESICM) and the Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) therefore decided to develop a set of recommendations for application in non-immunocompromised critically ill patients.
Literatur
24.
26.
Zurück zum Zitat Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758CrossRefPubMedPubMedCentral Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Paphitou NI, Ostrosky-Zeichner L, Rex JH (2005) Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 43:235–243CrossRefPubMed Paphitou NI, Ostrosky-Zeichner L, Rex JH (2005) Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 43:235–243CrossRefPubMed
31.
Zurück zum Zitat Michalopoulos AS, Geroulanos S, Mentzelopoulos SD (2003) Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 124:2244–2255CrossRefPubMed Michalopoulos AS, Geroulanos S, Mentzelopoulos SD (2003) Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 124:2244–2255CrossRefPubMed
52.
Zurück zum Zitat Mikulska M, Calandra T, Sanguinetti M et al (2010) The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 14:R222. https://doi.org/10.1186/cc9365 Mikulska M, Calandra T, Sanguinetti M et al (2010) The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 14:R222. https://​doi.​org/​10.​1186/​cc9365
55.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C. Clin Infect Dis 46:1813–1821. https://doi.org/10.1086/588660 CrossRefPubMed De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C. Clin Infect Dis 46:1813–1821. https://​doi.​org/​10.​1086/​588660 CrossRefPubMed
59.
65.
Zurück zum Zitat Playford EG, Webster AC, Sorrell TC, Craig JC (2006) Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 57:628–638. https://doi.org/10.1093/jac/dki491 CrossRefPubMed Playford EG, Webster AC, Sorrell TC, Craig JC (2006) Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 57:628–638. https://​doi.​org/​10.​1093/​jac/​dki491 CrossRefPubMed
66.
Zurück zum Zitat Shorr AF, Chung K, Jackson WL et al (2005) Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 33:1928–1935 (quiz 1936) CrossRefPubMed Shorr AF, Chung K, Jackson WL et al (2005) Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 33:1928–1935 (quiz 1936) CrossRefPubMed
72.
Zurück zum Zitat Bow EJ, Evans G, Fuller J et al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 21:e122–e150CrossRefPubMedPubMedCentral Bow EJ, Evans G, Fuller J et al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 21:e122–e150CrossRefPubMedPubMedCentral
76.
Zurück zum Zitat Piarroux R, Grenouillet F, Balvay P et al (2004) Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443–2449CrossRefPubMed Piarroux R, Grenouillet F, Balvay P et al (2004) Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443–2449CrossRefPubMed
79.
Zurück zum Zitat Golan Y, Wolf MP, Pauker SG et al (2005) Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 143:857–869CrossRefPubMed Golan Y, Wolf MP, Pauker SG et al (2005) Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 143:857–869CrossRefPubMed
80.
Zurück zum Zitat Schuster MG, Edwards JE, Sobel JD et al (2008) Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 149:83–90CrossRefPubMed Schuster MG, Edwards JE, Sobel JD et al (2008) Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 149:83–90CrossRefPubMed
99.
Zurück zum Zitat Chen Q, Lin M-H, Chen M-L et al (2012) Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials. Chin Med J (Engl) 125:345–351 Chen Q, Lin M-H, Chen M-L et al (2012) Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials. Chin Med J (Engl) 125:345–351
110.
Zurück zum Zitat Muakkassa FK, Ghannoum M (2016) Updates on therapeutic strategies against Candida (and Aspergillus) biofilm related infections. Springer, Cham, pp 95–103 Muakkassa FK, Ghannoum M (2016) Updates on therapeutic strategies against Candida (and Aspergillus) biofilm related infections. Springer, Cham, pp 95–103
111.
Zurück zum Zitat Chaves F, Garnacho-Montero J, Del Pozo JL et al (2018) Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish society of infectious diseases and clinical microbiology and (SEIMC) and the Spanish society of Spanish society of intensive and critical care medicine A. Med Intens 42:5–36. https://doi.org/10.1016/j.medin.2017.09.012 CrossRef Chaves F, Garnacho-Montero J, Del Pozo JL et al (2018) Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish society of infectious diseases and clinical microbiology and (SEIMC) and the Spanish society of Spanish society of intensive and critical care medicine A. Med Intens 42:5–36. https://​doi.​org/​10.​1016/​j.​medin.​2017.​09.​012 CrossRef
115.
Zurück zum Zitat Martínez-Jiménez MC, Muñoz P, Valerio M et al (2015) Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment. J Antimicrob Chemother 70:3107–3115. https://doi.org/10.1093/jac/dkv241 CrossRefPubMed Martínez-Jiménez MC, Muñoz P, Valerio M et al (2015) Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment. J Antimicrob Chemother 70:3107–3115. https://​doi.​org/​10.​1093/​jac/​dkv241 CrossRefPubMed
124.
Zurück zum Zitat Ostrosky-Zeichner L, Shoham S, Vazquez J et al (2014) MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis 58:1219–1226. https://doi.org/10.1093/cid/ciu074 CrossRefPubMed Ostrosky-Zeichner L, Shoham S, Vazquez J et al (2014) MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis 58:1219–1226. https://​doi.​org/​10.​1093/​cid/​ciu074 CrossRefPubMed
Metadaten
Titel
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
verfasst von
Ignacio Martin-Loeches
Massimo Antonelli
Manuel Cuenca-Estrella
George Dimopoulos
Sharon Einav
Jan J. De Waele
Jose Garnacho-Montero
Souha S. Kanj
Flavia R. Machado
Philippe Montravers
Yasser Sakr
Maurizio Sanguinetti
Jean-Francois Timsit
Matteo Bassetti
Publikationsdatum
25.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 6/2019
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-019-05599-w

Weitere Artikel der Ausgabe 6/2019

Intensive Care Medicine 6/2019 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.